Keyphrases
Systematic Literature Review
100%
Antiphospholipid Syndrome
100%
Thrombin Generation Assay
100%
Thrombin Generation
63%
Activated Protein C Resistance
36%
Thrombotic
36%
Healthy Controls
18%
Risk Assessment
18%
Antiphospholipid Antibodies
18%
Calibrated Automated Thrombogram
18%
Syndrome Diagnosis
18%
Newcastle-Ottawa Scale
18%
Autoimmune Disease
9%
Diagnostic Value
9%
No Significant Difference
9%
Odds Ratio
9%
Quality Assessment
9%
France
9%
Inclusion Criteria
9%
MEDLINE
9%
Data Extraction
9%
Control Subjects
9%
Embase
9%
Exclusion Criteria
9%
Lag Time
9%
Disease Control
9%
Fully Automated
9%
Search Strategy
9%
Current Diagnostics
9%
Prognostic Value
9%
Time to Peak
9%
Diagnostic Strategy
9%
Platelet-poor Plasma
9%
Platelet-rich Plasma
9%
Chromogenic Substrate
9%
Endogenous Thrombin Potential
9%
Activated Protein C
9%
Peak Height
9%
Adverse Pregnancy Outcomes
9%
Data Quality
9%
Data Synthesis
9%
Fluorogenic Substrate
9%
Systemic Review
9%
ST Genesia
9%
Synthesis without Meta-analysis
9%
Antibody Carrier
9%
Stago
9%
INIS
patients
100%
applications
100%
reviews
100%
thrombin
100%
control
63%
comparative evaluations
45%
proteins
45%
data
18%
antibodies
18%
values
18%
synthesis
18%
peaks
18%
risk assessment
18%
substrates
18%
plasma
18%
diseases
9%
assessments
9%
height
9%
guidelines
9%
inclusions
9%
carriers
9%
france
9%
extraction
9%
obstetrics
9%
Medicine and Dentistry
Systematic Review
100%
Thrombin
100%
Antiphospholipid Syndrome
100%
Activated Protein C Resistance
36%
Diagnosis
18%
Antiphospholipid Antibody
18%
Prevalence
9%
Meta-Analysis
9%
Obstetrics
9%
Thrombocyte Rich Plasma
9%
Thrombocyte Poor Plasma
9%
Autoimmune Disease
9%
Activated Protein C
9%
Chromogenic Substrate
9%
Odds Ratio
9%
Biochemistry, Genetics and Molecular Biology
Antiphospholipid Syndrome
100%
Thrombin
100%
Activated Protein C Resistance
36%
Antiphospholipid Antibody
18%
Prevalence
9%
Platelet-Poor Plasma
9%
Embase
9%
Platelet-Rich Plasma
9%
Data Extraction
9%
Data Synthesis
9%
Protein C
9%
Neuroscience
Thrombin
100%
Antiphospholipid Syndrome
100%
Activated Protein C
45%
Phospholipid Antibody
18%
Blood Plasma
18%
Platelet
18%
Meta-Analysis
9%
Autoimmune Disease
9%
Immunology and Microbiology
Antiphospholipid Syndrome
100%
Thrombin
100%
Phospholipid Antibody
18%
Prevalence
9%
Autoimmune Disease
9%
Platelet-Poor Plasma
9%
Embase
9%
Data Extraction
9%
Platelet-Rich Plasma
9%
Data Synthesis
9%